Meningioma Clinical Trials in San Francisco, California
7 recruitingSan Francisco, California
Showing 1–7 of 7 trials
Recruiting
Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation
Alliance for Clinical Trials in Oncology124 enrolled780 locationsNCT02523014
Recruiting
Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
Brain TumorMeningiomaMeningioma of Brain
University of California, San Francisco3,000 enrolled1 locationNCT07418775
Recruiting
Not Applicable
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
MeningiomaRecurrent MeningiomaMeningioma, Malignant
University of California, San Francisco23 enrolled1 locationNCT06557512
Recruiting
Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Grade 2 MeningiomaIntracranial Meningioma
NRG Oncology163 enrolled214 locationsNCT03180268
Recruiting
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain TumorBrain Tumor - MetastaticBrain Tumor, Recurrent+3 more
GT Medical Technologies, Inc.600 enrolled54 locationsNCT04427384
Recruiting
Phase 1
Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
Meningioma
Javier Villaneuva-Meyer, MD50 enrolled1 locationNCT06014905
Recruiting
Phase 2
Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma
Grade I Meningioma, AdultGrade II Meningioma, AdultGrade III Meningioma, Adult+1 more
Nancy Ann Oberheim Bush, MD37 enrolled1 locationNCT04659811